Exact Mass: 353.0197

Exact Mass Matches: 353.0197

Found 90 metabolites which its exact mass value is equals to given mass value 353.0197, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5'-Hydroxytenoxicam

(3Z)-3-{hydroxy[(5-hydroxypyridin-2-yl)amino]methylidene}-2-methyl-2H,3H,4H-1λ⁶-thieno[2,3-e][1,2]thiazine-1,1,4-trione

C13H11N3O5S2 (353.014)

5-Hydroxytenoxicam is only found in individuals that have used or taken Tenoxicam. 5-Hydroxytenoxicam is a metabolite of Tenoxicam. 5-hydroxytenoxicam belongs to the family of Thienothiazines. These are heterocyclic compounds containing a thiophene ring fused to a thiazine.

4'-Hydroxy-5-carboxy-lumiracoxib

3-{[2-(carboxymethyl)-4-methylphenyl]amino}-4-chloro-2-fluoro-6-hydroxybenzoic acid

C16H13ClFNO5 (353.0466)

4-Hydroxy-5-carboxy-lumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)

Naringenin 5-sulfate

{4-[7-hydroxy-4-oxo-5-(sulphooxy)-3,4-dihydro-2H-1-benzopyran-2-yl]phenyl}oxidanium

C15H13O8S (353.0331)

7-(3-Isothiocyanatopyrrolidin-1-yl)-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide

4-(3-Isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2,1,3-benzoxadiazole

C13H15N5O3S2 (353.0616)

Aceclofenac

2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid carboxymethyl ester

C16H13Cl2NO4 (353.0222)

M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Clopidogrel thiol

Methyl 2-(2-chlorophenyl)-2-sulphanyl-2-{4h,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetic acid

C16H16ClNO2S2 (353.0311)

Daltroban

2-[4-[2-[(4-Chlorophenyl)sulphonylamino]ethyl]phenyl]acetic acid

C16H16ClNO4S (353.0489)

Flosulide

N-[6-(2,4-difluorophenoxy)-1-oxo-2,3-dihydro-1H-inden-5-yl]methanesulfonamide

C16H13F2NO4S (353.0533)

D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators

Clonazolam

C17H12ClN5O2 (353.0679)

5-Hydroxytenoxicam

C13H11N3O5S2 (353.014)

PharmaGSID_48505

C17H12ClN5O2 (353.0679)

CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4766; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4776; ORIGINAL_PRECURSOR_SCAN_NO 4773 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4805; ORIGINAL_PRECURSOR_SCAN_NO 4803 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4769; ORIGINAL_PRECURSOR_SCAN_NO 4767 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4827; ORIGINAL_PRECURSOR_SCAN_NO 4826 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9149; ORIGINAL_PRECURSOR_SCAN_NO 9147 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9178; ORIGINAL_PRECURSOR_SCAN_NO 9177 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9199; ORIGINAL_PRECURSOR_SCAN_NO 9197 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9243; ORIGINAL_PRECURSOR_SCAN_NO 9240 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9252; ORIGINAL_PRECURSOR_SCAN_NO 9247 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9252; ORIGINAL_PRECURSOR_SCAN_NO 9249

ACMC-20ld4d

C14H16BrN3OS (353.0197)

Isolissoclinotoxin B

C11H15NO2S5 (352.9706)

p-Bromobenzyl ester-Clavulanic acid,BAN,INN

C14H12BrNO5 (352.9899)

(-)-Eudistomin K|Eudistomin K|eudistomin K trifluoroacetate

C14H16BrN3OS (353.0197)

Famotidine sulfoxide

3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide

C8H15N7O3S3 (353.0398)

H 152/66

Clevidipine Impurity 7

C16H13Cl2NO4 (353.0222)

Hydroxytenoxicam

C13H11N3O5S2 (353.014)

2-Hydroxytenoxicam

C13H11N3O5S2 (353.014)

Nitromersol

C7H5HgNO3 (352.9976)

Gadolinium(III) acetate hexahydrate

C6H11GdO7 (352.9746)

4-[[4-(dimethylamino)phenyl]carbamoylamino]benzenesulfonyl chloride

C15H16ClN3O3S (353.0601)

N-(2-iodophenyl)-4-methoxybenzamide

C14H12INO2 (352.9913)

2-(2-CHLORO-ACETYLAMINO)-4-(4-METHOXY-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C16H16ClNO4S (353.0489)

Thiazolidine, 3-[(4-chlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C16H16ClNO2S2 (353.0311)

(S)-(+)-ALPHA-METHYL-1H-IMIDAZOLE-4-ETHANAMINEDIHYDROBROMIDE

C13H15N5O3S2 (353.0616)

(1Z)-4-chloro-3-sulfamoyl-N-(2,4,6-trimethylpyridin-1-ium-1-yl)benzenecarboximidate

C15H16ClN3O3S (353.0601)

4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide

C13H15N5O3S2 (353.0616)

Buthiazide

C11H16ClN3O4S2 (353.0271)

C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

5-BROMO-2-CHLORO-N-(4-METHOXYBENZYL)BENZAMIDE

C15H13BrClNO2 (352.9818)

4-[3-(4-CARBAMOYL-PHENYL)UREIDO]BENZENESULFONYLCHLORIDE

C14H12ClN3O4S (353.0237)

4-((2-AMINOPHENYL)THIO)-N,N-DIMETHYL-3-NITROBENZENESULFONAMIDE

C14H15N3O4S2 (353.0504)

(-)-TRANS-MYRTANYLACETATE

C9H9F6N3O3S (353.0269)

Diethyl thiophosphoril (Z)-(2-aminothiazol-4-yl)-(methoxyimino)acetate

C10H16N3O5PS2 (353.0269)

Glyparamide

C15H16ClN3O3S (353.0601)

(2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(2-NITROPHENOXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

C12H12KNO9 (353.0149)

Ibacitabine

5-Iodo-2-deoxycytidine

C9H12IN3O4 (352.9873)

D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

2-Butenoic acid,4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-, (2Z)-

C13H11N3O5S2 (353.014)

terofenamate

C17H17Cl2NO3 (353.0585)

(4-methylphenyl) 2-amino-5-iodobenzoate

C14H12INO2 (352.9913)

p-aminophenylmercuric acetate

C8H9HgNO2 (353.034)

N-(4-Bromo-2-formylphenyl)-4-methylbenzenesulfonamide

C14H12BrNO3S (352.9721)

Quinfamide

C16H13Cl2NO4 (353.0222)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

5,7-BIS(TRIFLUOROMETHYL)-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C14H9F6NO3 (353.0487)

bis(triphenylphosphine)iminium nitrite

[(C6H5)3P=]2N(ONO) (353.0609)

IMR-1

C15H15NO5S2 (353.0392)

Daltroban

C16H16ClNO4S (353.0489)

D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C26170 - Protective Agent > C2079 - Cardioprotective Agent

2-DEOXYADENOSINE 3-MONOPHOSPHATE SODIUM SALT

C10H13N5NaO6P (353.0501)

N7-(3-CHLOROPHENYL)-N2-PHENYLTHIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE

C17H12ClN5S (353.0502)

2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluoro-phe noxy]acetic acid

C16H13ClFNO5 (353.0466)

6-methyl-3-nitrobenzoxamercurete

C7H5HgNO3 (352.9976)

tris(cyclopentadienyl)gadolinium

C15H15Gd (353.0415)

6-Hydroxymethylpterin-diphosphate

C7H9N5O8P2 (352.9926)

Dabuzalgron hydrochloride

C12H17Cl2N3O3S (353.0368)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

Glionitrin A

C13H11N3O5S2 (353.014)

A pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring. It is an antibiotic isolated from the microbial strains Sphingomonas and Aspergillus fumigatus, and exhibits cytotoxic activity against four human cancer cell lines: HCT-116, A549, AGS, and DU145. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

(1s,11s)-11-(hydroxymethyl)-15-methyl-6-nitro-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

C13H11N3O5S2 (353.014)